Company Monitoring Page for Regeneron

latest headlines for company on cafepharma

Regeneron drug highly effective for those who can't take statins: study
Reuters
Tue, 11/18/14 - 03:49 pm
Tags:
Regeneron, statins, Sanofi, alirocumab
Long-Awaited Study Boosts Merck, Could Be Good News for Regeneron, Amgen
Barron's
Mon, 11/17/14 - 04:03 pm
Tags:
Merck, Vytorin, Amgen, Regeneron
Sanofi's dual-action biotech asthma drug performs well in test
Yahoo/Reuters
Tue, 11/11/14 - 08:57 am
Tags:
Sanofi, asthma, dupilumab, Regeneron
Eyeing Eylea's heirs, Regeneron spends more and more on R&D
Fierce Biotech
Wed, 11/5/14 - 08:15 am
Tags:
Eylea, Regeneron, R&D
Four Biotechs Lead Health Care Stocks In Big Cap 20
Investors.com
Tue, 10/28/14 - 08:44 am
Tags:
Alexion, Amgen, Celgene, Regeneron
Biogen Leads 5 Top Biotech Stocks As Earnings Loom
Investors.com
Tue, 10/21/14 - 09:55 pm
Tags:
Biogen Idec, earnings, Celgene, Alexion, Regeneron, Gilead Sciences
Sanofi, Regeneron start Phase 3 trial of dupilumab in eczema
Yahoo/Reuters
Mon, 10/20/14 - 08:17 am
Tags:
Sanofi, Regeneron, dupilumab, eczema
Amgen Files Lawsuit Against Sanofi And Regeneron For Patent Infringement
Yahoo
Fri, 10/17/14 - 09:56 am
Tags:
Amgen, Sanofi, Regeneron, patents, alirocumab, monoclonal antibodies, evolocumab
Regeneron's Eylea works better vs Avastin and Lucentis in study
Yahoo/Reuters
Fri, 10/17/14 - 09:50 am
Tags:
Regeneron, Eylea, Avastin, Lucentis, diabetic macular edema
Sanofi posts positive results for drug in chronic sinusitis
Yahoo/Reuters
Tue, 09/30/14 - 08:41 am
Tags:
Sanofi, chronic sinusitis, Regeneron, dupilumab
Regeneron touts its allergy drug as a blockbuster in waiting
Fierce Biotech
Mon, 09/22/14 - 09:37 am
Tags:
Regeneron, allergy, alirocumab, dupilumab
Asthma: It’s a mAb, mAb, mAb, mAb world says analyst
Bio-Pharma Reporter
Fri, 09/5/14 - 11:20 am
Tags:
asthma, monoclonal antibodies, Sanofi, Regeneron, Roche, GSK, AstraZeneca
Sanofi and Regeneron Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014
Yahoo/PR Newswire
Sun, 08/31/14 - 09:56 am
Tags:
Sanofi, Regeneron, alirocumab, hypercholesterolemia
Who's worried about the drug-pricing debate? Regeneron's CEO, for one
Fierce Pharma
Thu, 08/28/14 - 09:59 am
Tags:
drug pricing, Regeneron, Pharma CEOs, Leonard Schleifer
Jazz, Celgene Lead Top 4 Drugmaker Profit Margins
Investors.com
Mon, 08/18/14 - 04:21 pm
Tags:
earnings, Jazz Pharmaceuticals, Celgene, Alexion, Regeneron
Most popular news headlines for Wednesday, August 6 2014
CP Wire
Thu, 08/7/14 - 07:56 am
Tags:
CVS Caremark, Express Scripts, Sanofi, Regeneron, Amgen, Ian Read, Physician Payment Sunshine Act
Thu, 08/7/14 - 07:54 am
Tags:
Sanofi, Regeneron, Physician Payment Sunshine Act, Ian Read, Express Scripts, CVS Caremark, Amgen
As race to market intensifies, how expectant are cardiologists for PCSK9 inhibitor class?
First Word Pharma
Wed, 08/6/14 - 10:11 am
Tags:
cardiologists, physicians, PCSK9 inhibitors, Sanofi, Regeneron, Amgen, evolocumab, alirocumab
4 Top Drugmakers Deliver Solid Doses Of Earnings Growth
Yahoo/Investors Business Daily
Wed, 08/6/14 - 08:10 am
Tags:
earnings, Actavis, Jazz Pharmaceuticals, Akorn, Regeneron
Regeneron sales top forecast as Eylea picks up steam
Yahoo/Reuters
Tue, 08/5/14 - 10:01 am
Tags:
earnings, Eylea, Regeneron

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.